Tanios Bekaii-Saab, MD, discusses how community oncologists can play an important role in the advancement of gastrointestinal (GI) cancers despite not having access to major trials.
Tanios Bekaii-Saab, MD, a professor of medicine at the Mayo Clinic, discusses how community oncologists can play an important role in the advancement of gastrointestinal (GI) cancers despite not having access to major trials.
Now, more than ever, there is a better understanding of alterations, mutations, amplifications, and fusions that are drivers, Bekaii-Saab says. Many studies now are looking at colorectal cancer to develop agents for the various subgroups.
Survivorship Care Promotes Evidence-Based Approaches for Quality of Life and Beyond
March 21st 2025Frank J. Penedo, PhD, explains the challenges of survivorship care for patients with cancer and how he implements programs to support patients’ emotional, physical, and practical needs.
Read More